PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Overview Fund Activity
Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

45 hedge funds and large institutions have $8.62M invested in Pear Therapeutics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 3 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+30
Holders Change %
+200%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
3
Reduced
–
Closed
8
Calls
$2.76M
Puts
–
Net Calls
+$2.76M
Net Calls Change
+$2.74M

Top Buyers

1
RCM
Radcliffe Capital Management
Pennsylvania
$1.81M
2
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
$725K
3
AC
Aristeia Capital
Connecticut
$592K
4
KCM
Kingstown Capital Management
New York
$555K
5
KC
Kepos Capital
New York
$370K

Top Sellers

1
SCM
Saba Capital Management
New York
$0
2
BFM
Boothbay Fund Management
New York
$0
3
OCM
Oribel Capital Management
New York
$0
4
PAMP
Polar Asset Management Partners
Ontario, Canada
$0
5
FTCM
Fir Tree Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
51
Goldman Sachs
New York
– -$13K -13,180 Closed
DCM
52
DG Capital Management
New York
– -$8K -8,333 Closed
1 2
3